Chengdu Kangnuoxing Biopharma,inc.

This study tests a new drug called stapokibart for people with moderate to severe bullous pemphigoid, a painful blistering skin condition. About 200 adults will receive either the drug or a placebo to see if it helps them stop taking steroids and stay blister-free for 36 weeks. T…